Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 6/20 | 0.49 |
| ▸ | PPARD | Q03181 | 3/20 | 0.49 |
| ▸ | PPARA | Q07869 | 3/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | F7 | P08709 | 3/20 | 0.44 |
| ▸ | F3 | P13726 | 3/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.44 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30537451 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL30537450 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL4316052 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL14538124 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL31138123 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL2586056 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL594566 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL2984928 | 1.00 | PPARG (0.49) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL29896525 | 0.90 | PPARG (0.52) | PPARGPPARDPPARATRPA1NR4A2 | |
| SCHEMBL14035899 | 0.85 | DNTT (0.48) | PPARGPPARDPPARATRPA1NR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049318-A1 | INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION | UNIV GUELPH (CA) | 2026-02-19 | — | — | US | disclosed |
| EP-4642472-A1 | PLANT HYDROETHANOLIC EXTRACTS | O SIGMA CELL AND GENETIC LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4642471-A1 | PLANT HYDROETHANOLIC EXTRACTS AND USES THEREOF | IMMUNE & GENETICS PROTOCOLS LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2025038756-A1 | BIOACTIVE COMPOUNDS WITH PESTICIDE ACTIVITIES DERIVED FROM AGED CULTURES OF GREEN MICROALGAE | TEXAS TECH UNIVERSITY SYSTEM (US) | 2025-02-20 | — | — | WO | disclosed |
| WO-2024141931-A1 | PLANT HYDROETHANOLIC EXTRACTS | O SIGMA CELL AND GENETIC LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024141930-A1 | PLANT HYDROETHANOLIC EXTRACTS AND USES THEREOF | IMMUNE & GENETICS PROTOCOLS LLC (US) | 2024-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049318-A1 | INHIBITION OF PLANT PROTEASE AED3-1 FOR IMPROVED HETEROLOGOUS PROTEIN PRODUCTION | DPP3, IDE, NOTCH3 | PPARG 3677/4885PPARD 3566/4885PPARA 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.